NCT02073461View on ClinicalTrials.gov

Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.

PHASE2CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Acne Vulgaris
Interventions
DRUG

CD1579 2.5%

DRUG

CD1579 5%

DRUG

Vehicle

Trial Locations (6)

Unknown

Galderma investigational site, Fukuoka

Galderma investigational site, Amagasaki

Galderma investigational site, Kobe

Galderma investigational site, Nakano City

Galderma investigational site, Shibuya City

Galderma investigational site, Shinjuku

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT02073461 - Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. | Biotech Hunter | Biotech Hunter